Gene · 91543
Papers3,037
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,037
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Selective Whole-Blood Expression of Interferon-Stimulated Genes and TLR3/TLR7 in Type 1 Diabetes with Minimal Enterovirus-Targeted Amplification in Whole Blood. | Genes (Basel) | 2026 | 42792959 | PubTator, text mining | PubMed |
| Optineurin Restricts ZIKV Replication Through Promoting IFN-Mediated JAK/STAT Signaling Pathway. | J Med Virol | 2026 | 42747136 | PubTator, text mining | PubMed |
| Methamphetamine enhances HIV infection of human iPSC-derived microglia. | NeuroImmune Pharm Ther | 2026 | 42699847 | PubTator, text mining | PubMed |
| Integrated Functional Characterization of a Panel of Clinical Orthoflavivirus Isolates Reveals Distinct Replication and Innate Immune Response Profiles in Human Keratinocytes. | Viruses | 2026 | 42655646 | PubTator, text mining | PubMed |
| Histopathological Assessment of IFI6- and RSAD2-DNA Aptamers in Oral Squamous Cell Carcinoma: A Preliminary Study Based on In Silico Analysis. | Biomedicines | 2026 | 42652067 | PubTator, text mining | PubMed |
| Lipid droplet dynamics control type I interferon responses and viperin expression to suppress viral replication. | Vet Microbiol | 2026 | 42623889 | PubTator, text mining | PubMed |
| Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases. | Ann Rheum Dis | 2026 | 42618420 | PubTator, text mining | PubMed |
| Integrative Bioinformatics and Machine Learning Analysis Identifies Novel Molecular Biomarkers in Prostate Adenocarcinoma. | Int J Mol Sci | 2026 | 42589294 | PubTator, text mining | PubMed |
| RSAD2/VIPERIN and CMPK2 coordinate an immunometabolic response to Epstein-Barr Virus. | PLoS Pathog | 2026 | 42546073 | PubTator, text mining | PubMed |
| Viperin suppresses goose astrovirus type 2 replication through inhibition of viral RdRP activity. | Vet Res | 2026 | 42533335 | PubTator, text mining | PubMed |
| IFN-related gene expression defines disease activity, organ involvement and treatment response in JDM. | Rheumatology (Oxford) | 2026 | 42500994 | PubTator, text mining | PubMed |
| Discovery of an Antiviral Electron Transfer Process to Create Catalytically Self-Sufficient Viral Restriction Factors. | Angew Chem Int Ed Engl | 2026 | 42478895 | PubTator, text mining | PubMed |
| Functional and transcriptome analyses identify CMPK2 as a potential antiviral factor against NNV in Siniperca chuatsi. | Dev Comp Immunol | 2026 | 42468658 | PubTator, text mining | PubMed |
| Non-Cytopathic Mammalian Orthoreovirus Infection Triggers Innate Immune Responses in Human Tonsil-Derived Mesenchymal Stem Cells: Implications for Cell Therapy Quality Control. | Tissue Eng Regen Med | 2026 | 42467368 | PubTator, text mining | PubMed |
| TLR3 activation of microglia-containing cerebral organoid induces antiviral factors against HIV-1 infection. | Front Pharmacol | 2026 | 42453569 | PubTator, text mining | PubMed |
| Repeated aminoglycoside exposure activates interferon-stimulated genes in human renal proximal tubular models. | Arch Toxicol | 2026 | 42446670 | PubTator, text mining | PubMed |
| Single nuclear RNA sequencing shows altered microglial and astrocytic functions in post-mortem Parkinson's disease tissue. | BMC Genom Data | 2026 | 42401827 | PubTator, text mining | PubMed |
| Key molecular mechanisms of mitochondrial metabolic pathways in specific cell subpopulations of pancreatic cancer based on scRNA-seq and bulk RNA-seq. | PLoS One | 2026 | 42391245 | PubTator, text mining | PubMed |
| Differential Sensitivity of HSV-1 and PRV to IFN-λ Reveals a Neuron-Specific Antiviral Role for RSAD2. | bioRxiv | 2026 | 42282802 | PubTator, text mining | PubMed |
| Targeting HSP90ab1: curcumin and silybin inhibit NNV infection in sea perch (Lateolabrax japonicus) via receptor blockade and immune enhancement. | Fish Shellfish Immunol | 2026 | 42276435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/91543/papers